Hero
Madrid, Spain - ISMRM Workshop on Translational Cancer Imaging: From Acronym to Actuality
Madrid, Spain - ISMRM Workshop on Translational Cancer Imaging: From Acronym to Actuality
Program & Schedule
March 12 - 14, 2026
Universidad Autónoma de Madrid, Madrid, Spain

Join this event's community space!

Connect with other registrants for this event through our One Community Hub, included with registration of this event.

Click here to visit HigherLogic

Workshop Overview

The ISMRM Workshop on Translational Cancer Imaging: From Acronym to Actuality is a comprehensive two and a half-day event that aims to bridge the gap between research and clinical practice in cancer imaging. The workshop, set to take place in Madrid, Spain, will cover a wide range of topics related to the use of imaging in cancer diagnosis, treatment planning, and monitoring.

The first session will focus on physicians' perspectives on the use of imaging in patient care for various cancers, including glioblastoma, breast cancer, prostate cancer, and HCC/kidney cancer. The second session will delve into advanced MRI techniques for cancer, such as diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE) MRI, magnetic resonance spectroscopy (MRS), and chemical exchange saturation transfer (CEST). The third and fourth sessions will explore the applications of cancer imaging, including genotyping and phenotyping, early detection, stratification, risk characterization, biomarkers for predicting and monitoring therapy response, and image-guided and adaptive therapy. Specific imaging techniques and applications, such as prostate bi-parametric screening, preclinical imaging, PET/MR, radio-genomics, MR-Linac, and intra-operative MRI, will be discussed.

The final session will focus on cancer image analysis, covering topics such as artificial intelligence (AI), machine learning, deep learning, multi-modality imaging, mathematical modeling, and omics. Throughout the workshop, attendees will have the opportunity to participate in oral presentations, poster sessions, and round table discussions, fostering collaboration and knowledge sharing among professionals from various backgrounds.

Overall, the ISMRM Workshop on Translational Cancer Imaging aims to provide a platform for radiologists, oncologists, radiation oncologists, medical physicists, imaging scientists, and researchers to discuss the latest developments, challenges, and opportunities in translational cancer imaging, ultimately working towards improving patient care and outcomes.


Target Audience

The target audience for the ISMRM Workshop on Translational Cancer Imaging will be a multidisciplinary group of professionals involved in cancer imaging research and clinical applications. This likely will include MR physicists, radiologists, oncologists, radiation oncologists, medical physicists, imaging scientists, and researchers working in the field of cancer imaging.

The workshop covers a wide range of topics, from physicians' perspectives on imaging in patient care to advanced MRI techniques, applications of cancer imaging, and image analysis using AI and machine learning. The diverse content aims to bring together individuals from various backgrounds to discuss and learn about the latest developments, challenges, and opportunities in translational cancer imaging.

The workshop's focus on translating imaging advances into clinical practice further indicates that it is designed for professionals interested in bridging the gap between research and patient care.


Educational Objectives

Upon completion of this activity, participants should be able to:

  • Summarize physicians' perspectives on the use of imaging in patient care for various cancers, including glioblastoma, breast cancer, prostate cancer, and HCC/kidney cancer, and how imaging advances can be translated into clinical practice;
  • Describe advanced MRI techniques for cancer, such as diffusion-weighted imaging (DWI), dynamic contrast-enhanced (DCE) MRI, magnetic resonance spectroscopy (MRS), and chemical exchange saturation transfer (CEST), and their applications in cancer diagnosis, treatment planning, and monitoring; and
  • Describe the latest developments in cancer image analysis, including the use of artificial intelligence (AI), machine learning, deep learning, multi-modality imaging, mathematical modeling, and omics, and understand how these techniques can be applied to improve cancer imaging and patient care.


Conference Program

All times shown in CET

Jump to:
Thursday, March 12, 2026
Registration
102-01 Speaker Upload Available
07:30 - 08:30
Foyer
Welcome
101-01 Event
08:30 - 08:40
Great Hall (Aula Magna)
Great Hall (Aula Magna)
4 presentations
Invited Talk The Role of Clinical Imaging in the Management of Paediatric Brain Tumours
08:40 - 09:00
101-02-001
No syllabus uploaded No recording
Invited Talk Use of Advanced Imaging in Prostate Cancer Staging, Radiation Treatment Planning, and Surveillance
09:00 - 09:20
101-02-002
No syllabus uploaded No recording
Invited Talk Breast MRI in Cancer Care: Clinical Utility, Evolving Evidence, and Future Directions
09:20 - 09:40
101-02-004
Basak Dogan - UT Southwestern Medical Center, Dallas, United States of America
No recording
Invited Talk Round Table Discussion: Questions and Answers
09:40 - 10:10
101-02-005
Basak Dogan - UT Southwestern Medical Center, Dallas, United States of America
No syllabus uploaded No recording
Break
Speaker Upload Available
10:10 - 10:40
Foyer
Foyer
3 presentations
#00018 QSM-Derived Histogram and Intratumoral Susceptibility Features for Non-Invasive Glioma Grading
10:40 - 10:50
102-02-001 vahid Shahmaei - Shahid Beheshti University of Medical science, Tehran, Iran (Islamic Republic of)
Presented by: Forough Sodaei
Abstract Withdrawn No recording
#00030 Habitat Risk Score Depicts Differential Lesion Growth in Longitudinal MRIs of Patients on Active Surveillance
10:50 - 11:00
102-02-002 Veronica Wallaengen - University of Miami, Miami, United States of America
Presented by: Radka Stoyanova
No recording
#00054 Response-Aligned Reaction–Diffusion Modeling Reveals Prognostic Tumor Kinetics in Glioblastoma
11:00 - 11:10
102-02-003 Biprojit Nath - Medical College of Wisconsin, Milwaukee, United States of America
No recording
Great Hall (Aula Magna)
3 presentations
Invited Talk United Imaging
11:10 - 11:25
102-03-001
No syllabus uploaded No recording
Invited Talk GE HealthCare
11:25 - 11:35
102-03-002
José de Arcos - King's College, London, United Kingdom
No syllabus uploaded No recording
Invited Talk Questions and Answers
11:35 - 11:40
102-03-003
José de Arcos - King's College, London, United Kingdom
No syllabus uploaded No recording
Lunch Break and Poster Viewing
Speaker Upload Available
11:40 - 13:40
Foyer
Great Hall (Aula Magna)
5 presentations
Invited Talk Diffusion MR Microscopy for Cancer Imaging
13:40 - 14:00
101-03-001
Dan Wu - Zhejiang University, Hangzhou, China
No recording
Invited Talk Deuterium Metabolic Imaging for Cancer Research: Principles, Practice, and Potential
14:00 - 14:20
101-03-002
Evita Wiegers - University Medical Center Utrecht, Utrecht, Netherlands
No recording
Invited Talk MR Spectroscopy
14:20 - 14:40
101-03-003
Janine Lupo - University of California San Francisco, San Francisco, United States of America
No syllabus uploaded No recording
Invited Talk Amide Proton Transfer weighted CEST MRI in Cancers of the Brain and Beyond
14:40 - 15:00
101-03-004
Jochen Keupp - Philips Innovative Technologies, Hamburg, Germany
No recording
Invited Talk Round Table Discussion: Questions and Answers
15:00 - 15:30
101-03-005
Dan Wu - Zhejiang University, Hangzhou, China
Evita Wiegers - University Medical Center Utrecht, Utrecht, Netherlands
Janine Lupo - University of California San Francisco, San Francisco, United States of America
Jochen Keupp - Philips Innovative Technologies, Hamburg, Germany
No syllabus uploaded No recording
Break and Poster Viewing
Speaker Upload Available
15:30 - 16:00
Foyer
Foyer
3 presentations
#00006 Multiparametric MRI of Mouse-INtraDuctal (MIND) models of human invasive lobular breast carcinoma
16:00 - 16:10
102-05-001 Clementine Lesbats - The Institute of Cancer Research, Sutton, United Kingdom
No recording
#00014 Evaluation of Stimulated Echo Diffusion Weighted Imaging in Patients with Suspected Prostate Cancer
16:10 - 16:20
102-05-002 Srijyotsna Volety - University of Wisconsin - Madison, Madison, United States of America
No recording
#00025 Application of Radiomics Based on MR Cytometry Parameter Mapping in Differentiating Benign and Malignant Breast Tumors
16:20 - 16:30
102-05-003 Xinyi Luo - Tsinghua University, Beijing, China
No recording
Adjournment
16:30
Friday, March 13, 2026
Registration
202-01 Speaker Upload Available
07:30 - 08:30
Foyer
Great Hall (Aula Magna)
6 presentations
Moderators: Mahsa Servati, Yan Li
Invited Talk From Cells to Systems: Multi-Scale Cancer Imaging for Biomarker Discovery
08:30 - 08:50
201-01-001
C. Chad Quarles - The University of Texas MD Anderson Cancer Center, Houston, United States of America
No recording
Invited Talk Detecting Oligo-Metastatic Disease in Prostate Cancer
08:50 - 09:10
201-01-002
Tom Scheenen - Radboud University Medical Center, Nijmegen, Netherlands
No recording
Invited Talk PET/MRI in Cancer: Lessons Learned Through Our 10-Year Journey
09:10 - 09:30
201-01-003
Tone Bathen - Norwegian University of Science and Technology NTNU, Norway
No syllabus uploaded No recording
Invited Talk Radiogenomics for Cancer Characterization: Insights from Kidney and Breast Malignancies
09:30 - 09:50
201-01-004
Durga Udayakumar - Mayo Clinic, Rochester, United States of America
No recording
Invited Talk Round Table Discussion: Questions and Answers
09:50 - 10:20
201-01-005
C. Chad Quarles - The University of Texas MD Anderson Cancer Center, Houston, United States of America
Tom Scheenen - Radboud University Medical Center, Nijmegen, Netherlands
Tone Bathen - Norwegian University of Science and Technology NTNU, Norway
Durga Udayakumar - Mayo Clinic, Rochester, United States of America
No recording
Break Break, Speaker Upload Available, and Poster Viewing (30 min)
10:20 - 10:50
Invited Talk Negendank Lecture: MR Guided Interventions in Cancer
10:50 - 11:50
201-01-006
Clare Tempany - Harvard Medical School, Boston, United States of America
No syllabus uploaded No recording
Lunch Break and Poster Viewing
102-04 Speaker Upload Available
11:50 - 14:00
Foyer
Great Hall (Aula Magna)
4 presentations
Invited Talk Tumour Response to STING Activation Assessed with Multiparametric MRI
14:00 - 14:20
201-02-001
Simon Robinson - Institute of Cancer Research, London, United Kingdom
Recording withheld
Invited Talk Perfusion Imaging for Monitoring Brain Tumor Therapy
14:20 - 14:40
201-02-002
Jan Petr - Helmholtz-Zentrum Dresden Rossendorf, Germany
No recording
Invited Talk Advanced Imaging in the Neurosurgical Treatment of Intra-Axial Brain Tumors
14:40 - 15:00
201-02-003
Max Krucoff - Medical College of Wisconsin, Wauwatosa, United States of America
No syllabus uploaded No recording
Invited Talk Round Table Discussion: Questions and Answers
15:00 - 15:30
201-02-004
Simon Robinson - Institute of Cancer Research, London, United Kingdom
Jan Petr - Helmholtz-Zentrum Dresden Rossendorf, Germany
Max Krucoff - Medical College of Wisconsin, Wauwatosa, United States of America
No syllabus uploaded Recording withheld
Break
Speaker Upload Available
15:30 - 16:00
Foyer
Foyer
3 presentations
#00011 Multimodal AI-based Analysis for Predicting Tumor Hypoxia and Treatment Response in Oropharyngeal Cancer
16:00 - 16:10
202-03-001 Muhammad Awais - Memorial Sloan Kettering Cancer Center, New York, United States of America
Presented by: Amita Shukla-Dave
No recording
#00017 Radiomics & Longitudinal MRI to Predict and Monitor Oncolytic Virotherapy Response in Canine Gliomas
16:10 - 16:20
202-03-002 Ana González Aranda - Universidad Rey Juan Carlos, Móstoles, Spain
Presented by: Angel Torrado-Carvajal
No recording
#00024 Distance-to-tumor analysis of quantitative susceptibility maps in glioblastoma and association with survival
16:20 - 16:30
202-03-003 Alberto Galimberti - Medical University of Innsbruck, Innsbruck, Austria
No recording
Dean’s Office Entrance Hall
37 presentations
#00004 Understanding and imaging PHGDH-driven intrinsic resistance to mutant IDH inhibition in gliomas.
Poster #1
202-04-001 Celine Taglang - University of California San Francisco, San Francisco, United States of America
No recording
#00005 Metabolic response of diffuse midline glioma to PI3K inhibition in vivo assessed by dynamic 2H-MRS using [6,6-2H2]glucose
Poster #2
202-04-002 Declan Bolster - The Institute of Cancer Research, Sutton, United Kingdom
Presented by: Jessica Boult
No recording
#00008 DKI Biomarkers and ctDNA Kinetics: Tissue Microstructure and Molecular Signatures for Evaluating Cancer
Poster #3
202-04-003 Amita Shukla-Dave - Memorial Sloan Kettering Cancer Center, New York, United States of America
No recording
#00009 Bridging mpMRI and Histopathology for Tumor Microenvironment Insights in a Mouse Model of PDAC
Poster #4
202-04-004 Ramesh Paudyal - Memorial Sloan Kettering Cancer Center, New York, United States of America
Presented by: Amita Shukla-Dave
No recording
#00010 DKI for Evaluating Microstructural Changes in HPV-related Oropharyngeal Cancer Undergoing Radiation Therapy
Poster #5
202-04-005 Ramesh Paudyal - Memorial Sloan Kettering Cancer Center, New York, United States of America
Presented by: Amita Shukla-Dave
No recording
#00012 Deep Learning-Enabled MRI Framework for Histological Subtype Classification in Bladder Cancer
Poster #6
202-04-006 Muhammad Awais - Memorial Sloan Kettering Cancer Center, New York, United States of America
Presented by: Amita Shukla-Dave
No recording
#00013 Imaging heterogeneity and radiotherapy response in pre-clinical models of soft-tissue sarcoma with multi-parametric MRI
Poster #7
202-04-007 Ellen O'Sullivan - The Institute of Cancer Research, Sutton, United Kingdom
No recording
#00015 Glucosamine-CEST MRI in Breast Cancer: Correlation with BI-RADS Grade
Poster #8
202-04-008 Michal Rivlin - Tel Aviv University, Tel Aviv, Israel
Presented by: Gil Navon
No recording
#00016 Endogenous ROS MRI based on Kex enhancement and its initial clinical translation to glioma patients
Poster #9
202-04-009 Reisin Cai - Blue Valley Northwest High School, Overland Park, United States of America
Presented by: Kejia Cai
No recording
#00020 Aggressive Tumor Fraction as a Biomarker for Prostate Cancer Progression: Risk Assessment of Active Surveillance Patients
Poster #10
202-04-010 Veronica Wallaengen - University of Miami, Miami, United States of America
Presented by: Adrian Breto
No recording
#00023 Improved fat suppression for high-resolution DWI using a composite method
Poster #11
202-04-011 Fan Liu - Tsinghua University, Beijing, China
Presented by: Hua Guo
No recording
#00026 Variations in MR Cytometry Results across Different Acquisition Protocols for Prostate Imaging
Poster #12
202-04-012 Xinyi Luo - Tsinghua University, Beijing, China
Abstract Withdrawn No recording
#00027 The Impact of Perfusion Effect in MR Cytometry Imaging
Poster #13
202-04-013 Xinyi Luo - Tsinghua University, Beijing, China
Abstract Withdrawn No recording
#00028 Robustness and repeatability evaluation of a new spatial radiomics-based habitat map method: a test-retest MR phantom study
Poster #14
202-04-014 Karine Choquet - INSA-Lyon, UCBL, CNRS, Inserm, CREATIS UMR 5220, U1294, Lyon, France
No recording
#00029 Multicenter evaluation of a novel spatial radiomics-based habitat map method: an MRI phantom study
Poster #15
202-04-015 Karine Choquet - INSA-Lyon, UCBL, CNRS, Inserm, CREATIS UMR 5220, U1294, Lyon, France
No recording
#00031 On the origin of the brain semi-heavy water deuterium MR signal following administration of deuterated metabolic substrate
Poster #16
202-04-016 Joel Garbow - Washington University School of Medicine, St. Louis, United States of America
No recording
#00032 Two-Stage Subsampling Approach Identifies MRI Deep Features Associated with Response to NAC in Muscle-Invasive Bladder Cancer
Poster #17
202-04-017 Marinela Capanu - Memorial Sloan Kettering Cancer Center, New York, United States of America
Presented by: Amita Shukla-Dave
No recording
#00034 Contrast-Enhanced MRI-based Radiomics Framework for Classification of Indolent versus Aggressive Renal Cell Carcinoma
Poster #18
202-04-018 Salim Rukhsar - Mayo Clinic, Rochester, United States of America
Presented by: Durga Udayakumar
No recording
#00035 Tumor Treating Fields in Glioblastoma: Anatomical vs Metabolic Imaging Guided Targeting and Impact on Dosimetry Profiles
Poster #19
202-04-019 Sanjeev Chawla - University of Pennsylvania, Philadelphia, United States of America
No recording
#00036 The Role of CBV in Early Recurrence Risk Assessment in Patients with Glioblastoma
Poster #20
202-04-020 Mahsa Servati - The University of Texas MD Anderson Cancer Center, Houston, United States of America
No recording
#00037 Assessing Treatment Effects in T2 FLAIR Lesions and Normal-Appearing White Matter for Patients with Lower-Grade Gliomas
Poster #21
202-04-021 Tracy Luks - University Of California, San Francisco (UCSF), United States of America
No recording
#00039 Fat-removal Reconstruction for Improved Body DWI Fat Suppression
Poster #22
202-04-022 Aidan Tollefson - University of Wisconsin - Madison, Madison, United States of America
No recording
#00040 Segmentation of Rectal Tumor and Mesorectal Fascia on T2w-MRI for Preoperative Planning with Uncertainty Quantification
Poster #23
202-04-023 Blanca Rodriguez-Gonzalez - Universidad Rey Juan Carlos, Móstoles, Spain
Presented by: Angel Torrado-Carvajal
No recording
#00041 Optimized Slice-specific Shimming of Whole-body DWI in High-BMI Subjects
Poster #24
202-04-024 Aidan Tollefson - University of Wisconsin - Madison, Madison, United States of America
No recording
#00042 PET/MRI Radiomics in Pancreatic Cancer: A Pilot Study on the Correlation Between PET and MRI-Derived Image Features
Poster #25
202-04-025 Blanca Rodriguez-Gonzalez - Universidad Rey Juan Carlos, Móstoles, Spain
No recording
#00043 Quantifying Synthetic CT Uncertainty and Its Impact on PET/MR Attenuation Correction
Poster #26
202-04-026 Blanca Rodriguez-Gonzalez - Universidad Rey Juan Carlos, Móstoles, Spain
Presented by: Angel Torrado-Carvajal
No recording
#00044 On the Impact of Segmentation Variability on Radiomic Features Robustness in Oncology
Poster #27
202-04-027 Blanca Rodriguez-Gonzalez - Universidad Rey Juan Carlos, Móstoles, Spain
No recording
#00045 PET/MRI in cancer – lessons learned through our 10-year journey
Poster #28
202-04-028 Tone Bathen - Norwegian University of Science and Technology, Trondheim, Norway
No recording
#00046 Integration of Habitat Analysis in Novel Clinical Trial for Characterization of Ultra-early Response to Radiotherapy
Poster #29
202-04-029 Adrian Breto
No recording
#00048 Intra-tumoral Heterogeneity: Correlation between Histology and Diffusion MRI
Poster #30
202-04-030 Xiaohong Joe Zhou - University of Illinois Chicago, Chicago, United States of America
No recording
#00049 Spatial Heterogeneity of Cellular Composition and Stem Cell Markers Across MRI-Defined Tumor Regions in Glioblastoma
Poster #31
202-04-031 Benjamin Chao
No recording
#00050 Determination of an Optimal Stomach Filling Protocol to Improve Detection of Gastric Cancers Using Magnetic Resonance Imaging
Poster #32
202-04-032 Adam Cooper - Institute of Life Science, Swansea University, Singleton Park, Swansea. SA2 8PP, United Kingdom
No recording
#00051 Radiomic features of prostate cancer MRI reveals imaging biomarkers associated with PI-RADS and Gleason classifications.
Poster #33
202-04-033 Savannah Duenweg - Medical College of Wisconsin, Milwaukee, United States of America
No recording
#00052 Testing accuracy of self-distilled masked image transformer autosegmentation method on MR Images from head-and-neck cancer
Poster #34
202-04-034 Eve LoCastro - Memorial Sloan Kettering Cancer Center, New York, United States of America
Presented by: David Miller
No recording
#00053 Association of FET PET tumor volume and radio-pathomic maps of cell density in newly diagnosed and recurrent glioblastoma
Poster #35
202-04-035 Aleksandra Winiarz - Medical College of Wisconsin, Wauwatosa, United States of America
No recording
#00055 Radio-pathomic Features of Glioblastoma Differ in Cases with Autopsy Confirmed Brainstem Invasion
Poster #36
202-04-036 Mrina Mtenga - Medical College of Wisconsin, Wauwatosa, United States of America
Presented by: Biprojit Nath
No recording
#00056 Quantitative MRI to Identify Intraprostatic Tumor
Poster #37
202-04-037 Kun Qing - City of Hope Comprehensive Cancer Center, United States of America
No recording
Adjournment
18:30
Networking Reception
202-05 Event
18:30 - 20:30
Dean’s Office Entrance Hall
Saturday, March 14, 2026
Registration
302-01 Speaker Upload Available
08:00 - 08:30
Foyer
Great Hall (Aula Magna)
5 presentations
Invited Talk Multimodal Learning in Neuro-Oncology: From Imaging Radiomics to Omics Integration
08:30 - 08:50
301-01-001
Anahita Kazerooni - University of Pennsylvania, Philadelphia, United States of America
No recording
Invited Talk Human Lung Cancer Evaluation with NMR Metabolomics
08:50 - 09:10
301-01-002
Leo Cheng - Massachusetts General Hospital, Boston, United States of America
No syllabus uploaded No recording
Invited Talk Breast MRI With Computational Modeling and Deep Learning
09:10 - 09:30
301-01-003
Gene Kim - New York University, New York, United States of America
No recording
Invited Talk Human Brain Tumor Evolution: Seeing Cells, Tracking Mutations, and Exploiting Vulnerabilities
09:30 - 09:50
301-01-004
No recording
Invited Talk Round Table Discussion: Questions and Answers
09:50 - 10:20
301-01-005
Anahita Kazerooni - University of Pennsylvania, Philadelphia, United States of America
Leo Cheng - Massachusetts General Hospital, Boston, United States of America
Gene Kim - New York University, New York, United States of America
No syllabus uploaded No recording
Adjournment
10:20
Boxed Lunch
302-02 Event
10:20 - 11:20
Foyer

Organizing Committee

co-chair
Ananth Madhuranthakam, PhD
Mayo Clinic
Rochester, United States of America
co-chair
Pavithra Viswanath, PhD
University Of California, San Francisco (UCSF)

Committee Members

Harish Poptani, PhD
WS 96 - Cancer Imaging Organizers
Peter LaViolette, PhD
WS 96 - Cancer Imaging Organizers
Medical College of Wisconsin
Wauwatosa, United States of America
Samuel Bobholz, PhD
WS 96 - Cancer Imaging Organizers
Medical College of Wisconsin
Wauwatosa, United States of America
Brandy Reed, Graduate
WS 96 - Cancer Imaging Organizers
UT MD Anderson Cancer Center UTHealth Houston
Houston, United States of America
MASAKO KATAOKA, MD_PhD
WS 96 - Cancer Imaging Organizers
Kyoto University Hospital
Kyoto, Japan
Yan Li, MD_PhD
WS 96 - Cancer Imaging Organizers
University of California San Francisco
San Francisco, United States of America
Joel Garbow, PhD
WS 96 - Cancer Imaging Organizers
Washington University School of Medicine
St. Louis, United States of America
Jannie Wijnen, PhD
WS 96 - Cancer Imaging Organizers
UMC Utrecht
Utrecht, Netherlands

Registration

Important Deadlines

Early Registration Deadline: February 11, 2026 at 11:59 PM UTC

Registration Rates

In-Person Attendee Registration Rates

Registrant Type Fee
Member
2026 dues required
Early: $600.00
Late: $700.00
Nonmember
Early: $875.00
Late: $975.00
Trainee / Emeritus Member or ISMRT Technologist / Radiographer Member
2026 dues required; Trainees include postdocs, residents, fellows, and technologists
Early: $450.00
Late: $450.00
Trainee Nonmember or Nonmember Technologist / Radiographer
Trainees include postdocs, residents, fellows, and technologists
Early: $600.00
Late: $600.00
These fees include:

These fees include:

  • Workshop registration and materials
  • 3 lunches
  • Reception on Thursday, 12 March 2026
  • All morning and afternoon coffee/snack breaks during the workshop

Accommodations are not included in these fees. Registrants must book their own housing. See the Travel Info page for more information.

Cancellation Policy

  • All registration cancellation requests must be received via email only at registrar@ismrm.org by the above deadline.
  • Refunds are subject to a 20% cancellation fee.
  • There will be no refunds after the above deadline.
  • Registrations are not transferrable. No attendee may substitute for another.


Need an invoice or paying by cheque or wire?

You MUST register by filling out the printable registration form below and sending it to the Registrar for an invoice to be generated.

Special Notes

Receive the member discount on your registration by joining the ISMRM or ISMRT before you register!

  • Past members can simply log in here and either pay 2026 dues or apply for 2026 membership. Please do not create a new profile.
  • If you have never been a member of either ISMRM or ISMRT, please create a new profile here and then apply for membership.

Once your membership is approved, your registration options will automatically have the member discount!

Questions? Call us at +1 (510) 841-1899 or email membership@ismrm.org.


Accessibility & Dietary Needs

We encourage participation by all individuals. If you have a disability, food allergy, or other special need, advance notification will help us better accommodate you. Please notify us of your needs at least two weeks in advance of the program.


Visa Letter

If you need a Visa letter, please download and complete this self-fillable PDF letter.


Supporters

The ISMRM wishes to thank the following supporter for their contributions to Madrid, Spain - ISMRM Workshop on Translational Cancer Imaging: From Acronym to Actuality:

Exhibiting Companies

The International Society for Magnetic Resonance in Medicine (ISMRM) acknowledges and thanks its Corporate Members for their continued support of the Society:

Bronze Corporate Members

For Presenters & Attendees

Presentation Submission Guidelines

We strongly recommend uploading your presentation before the workshop (instructions will be emailed to all presenters). If you cannot upload before the deadline, then you must bring your presentation directly to the workshop meeting room on a USB storage device.


On-Site Presentation Computers & Software Provided

  • Internet access is NOT available on presentation computers.
  • The Windows computer will have the latest versions of the following software:
  • Microsoft Windows
  • Microsoft PowerPoint
  • Adobe Acrobat Reader
  • The Apple computer will have the latest versions of the following software:
  • MacOS
  • Microsoft PowerPoint
  • Apple Keynote
  • Installation of any additional software will not be permitted.


Loading Your Presentation On-Site

  • It is not possible to load your presentation once your session has begun. Please pre-load your presentation as early as possible.
  • You must use the provided computer at the presenter podium or table. There will be no connection to use your own laptop at the lectern.
  • Power Pitch slides CANNOT be submitted on-site. They must be submitted to the Workshop Manager before the event.
  • There is no speaker ready room.
  • The pre-loaded version does not need to be your final version, as long as you load your final version before your session begins. Draft versions can be loaded and later updated. You can do this simply to test the fonts, animations, and videos, and then bring your final version in before your scheduled time. By loading a draft version, any potential issues can be discovered and corrected prior to presentation.
  • Since editing time will be limited, please ensure that all fonts appear as expected and all sound/video clips are functioning properly. PowerPoint users can EMBED FONT to ensure your text appears as intended. Commercial fonts and Apple system fonts cannot be embedded. It is recommend to avoid these types of fonts.


Slide Presentation Guidelines

Showing Your Presentation

  • The A/V staff will start each presentation.
  • Once the presentation is launched, you will control the presentation from the lectern using a standard computer mouse.
  • The left button will advance to the next slide and start movies.
  • The right button will reverse to the previous slide. (Mac PowerPoint users will bring up a menu when the right mouse button is pressed.)
  • The mouse will also function as a pointer. No laser pointers are provided.
  • The sessions are digitally captured and a laser pointer cannot be recorded.
  • There will not be a keyboard. If you do not want the mouse pointer to disappear during the presentation, please consult the A/V staff when loading.


Preferred Presentation Formatting

  • This workshop will use a high-definition 16:9 format screen (see illustration), which can support a wide screen format.
  • To use the widescreen format, check your PAGE SETUP setting before creating your presentation.
  • Older versions of PowerPoint may have 4:3 as the default setting. Make sure to change this to ON-SCREEN SHOW (16:9) in order to make full use of the presentation screen.
  • Changing this setting after the presentation has been created can cause format issues on slides.
  • A presentation in the 4:3 format can be shown, but there will be black bars on both sides of the image (see example).
  • Video files should be embedded into the presentation. Do not use linked video files.
  • If using a video file for your presentation, it is imperative that it is tested on-site as early as possible to ensure it will play on the provided computers.
  • If a video does not play on the provided computers, it may take hours to fix, if it can be fixed at all.
  • Please note, just changing the file extension does not convert the file. Both free and commercial software is available for that purpose.
  • Set your presentation to Loop Continuously to prevent an accidental ending of recording during capture. This option is found under the SLIDE SHOW -> SETUP SLIDE SHOW menu in PowerPoint.
  • Please REMOVE ALL HYPERLINKS from any web address or e-mail addresses in your presentation. Simply highlight the text and select REMOVE HYPERLINK. An accidental click on a link will interrupt your presentation.


ISMRM Policy Regarding Presentation Slides

Content of CME activities will be restricted to pure science, industry issues, and operation of devices, and should not include any advertising, corporate logos, trade names or a product group message of an ACCME-defined ineligible company.

Presentations must give a balanced view of therapeutic options and use of generic names will contribute to this impartiality. Trade names or company names should only be used if essential. If included, where available trade names from several companies should be used, not just trade names from a single company.

How to Make a Video from Your Slideshow

Presenters can produce videos from their PowerPoint or Keynote slideshows. There are three main requirements for all videos submitted for inclusion in this conference:

Video Resolution: 1280x720 (720p)Video File Format: .MP4 (H.264 codec)Maximum video file size: 325 MB

Tips for Audio Recording:

  • Find a small, quiet space to record in.
  • Turn off loud machines and fans, especially air conditioners and heaters.
  • Avoid spaces with echo. Rooms with bare walls, such as bathrooms and kitchens, often produce noticeable echo.
  • Sound dampening (echo reduction) is easy and can be done with blankets, carpeting, curtains, furniture, and clothing. Soft items hung on a wall are great sound dampeners.
  • A closet full of clothes is a great space for recording.
  • Record yourself with a good headset or external microphone. Position the microphone just to the side of your mouth to reduce "pops" (bursts of air hitting the microphone, such as those produced by the letters p and b).
  • Avoid using a built-in microphone, such as on a laptop computer or webcam.
  • Speak loudly, clearly, and forcefully, as if you were outdoors and speaking to a group. The audience will not want to have to interpret mumbling or quiet speaking, and will lose interest or move on to the next video.
  • Make a brief test recording and review both the sound and picture quality. You may also want to double-check the MP4 format and bit rate before recording the entire presentation. Make adjustments if needed.


Making a Video in Microsoft PowerPoint

How to record narration and timings in PowerPoint: Microsoft Support Article

  • In the menu bar, click File
  • Click Export
  • Click Create a Video
  • In the Presentation Quality drop-down, select Internet Quality (1280 x 720)
  • Click Create Video
  • In the Save As dialog, go to the Save as type box and select "MPEG-4 Video (*.mp4)".
  • Enter a name in the File name box. Be sure to name your file according to the instructions on this website, under the appropriate tab for your presentation type.

For more detailed instructions, please visit Microsoft's website.

Be sure to select your version of PowerPoint from the options above "Save as a video file" to ensure the instructions cover your version of the software.

Making a Video in Apple Keynote

How to record narration and timings in Keynote: Apple Support Article

  • Click on the service menu on top of your screen File → Export To → Movie
  • If you recorded a narration, you can click the Playback pop-up menu, then choose Slideshow Recording. If you want the slides to advance by themselves, you can leave the option Self-Playing.
  • If you choose Self-Playing you can enter the time you want the next slide or build to advance. These timings apply only to click events.
  • On the Resolution drop-down menu, click Custom and enter 1280px x 720px. Be sure to select the H.246 option. This is .mp4 and it is going to work on any device and software.
  • Click Next…
  • Enter a name in the Save As field. Be sure to name your file according to the instructions on this website, under the appropriate tab for your presentation type.
  • To choose where to save the presentation, click the arrow next to the Where pop-up menu, then choose a location in the dialog. For example, it can be on the desktop. The default location Keynote chooses is the Keynote folder on your iCloud.
  • Finally, Click Export.

For more detailed instructions, please visit Apple's website.

Other software that can produce .MP4 files such as Camtasia or Zoom are also acceptable as long as the above file requirements are met.


Traditional Poster Guidelines

A traditional poster presentation combines a visual display on a poster board of the highlights of research with a question-and-answer opportunity. You will be assigned a time period during which you should be present at your poster for discussion and questions. In addition, the poster will be available for viewing by attendees during all hours the workshop is open.

Note: You must print your own poster, and it should be done before you leave for the workshop. Do not expect printing services on-site.

Measurements

Each presenter is assigned a square space with maximum dimensions of 36 inches wide by 36 inches high (approx. 91.44 cm x 91.44 cm). Posters exceeding these measurements (i.e., extending into areas reserved for other posters) may be removed.

Posters will be attached to their spaces with either tape or push-pins, which will be provided at the workshop.

Suggestions for Preparing Scientific Posters

Content
  • The poster should show the full title of your submission.
  • Text should be brief and well organized, presenting only enough data to support your conclusions.
  • The text should make clear the significance of your research.
  • The text should include (most likely as separate elements of the poster) your hypothesis, methods, results, and conclusions.


Design
  • A clear, simple, uncluttered arrangement is the most attractive and the easiest to read.
  • For best legibility, it is suggested that the title lettering be at least 2 inches (5cm) high, with authors' names and affiliations smaller.
  • All lettering should be legible from a distance of approximately 5 feet (1.5m). It is suggested that font size should be at least 24 point, in bold style. The typeface chosen should be a simple and clear one (e.g., Helvetica). Titles should be in all upper case letters. The remainder of the text should be in a combination of upper and lower case letters.
  • Color should be used sparingly, to provide contrast. The featured parts of the poster can be highlighted with warm colors, and the less important parts can be done in cool colors. Some suggestions for color combinations are as follows: Green on white, red on white, black on white, blue on white, white on blue, and white on black.
  • Illustrations should be simple and eye-catching, with unnecessary detail left out. If possible, convert tables to graphic displays. Pie graphs can be used to show parts of a whole, line graphs can be used to show trends or changing relationships, and bar graphs can be used to show volumes.
  • Photos should be enlarged enough to show relevant detail.
  • Standard computer printouts usually are not effective on posters, because the type is too small and the lines are too thin to be seen from a distance.
  • Patient confidentiality must be protected. No names should appear in illustrations.


Travel & Hotel Information

Welcome to the

Universidad Autónoma de Madrid (UAM) Faculty of Medicine

C. Arzobispo Morcillo, 4 Fuencarral-El Pardo, 28029 Madrid, Spain

Airport

The nearest airport to the UAM Faculty of Medicine is the Adolfo Suárez Madrid-Barajas (MAD) airport. It is 17.2 km (11 miles) away from the venue and is about a 30-minute car ride.

Car Rental

There are multiple car rental agencies that operate out of Terminal 1 and Terminal 4 of MAD. Rental car companies and their contact information can be viewed here.

Rideshare

The following companies offer pick-up and drop-off services from MAD in Terminals 1, 2, and 4:

Bolt

  • Terminal 1: P1 car park
  • Terminal 2: Express car park arrivals T2
  • Terminal 4: P4 car park. Module D, Floor 4

Grand Class

  • Terminal 1: P1 car park
  • Terminal 2: Express car park arrivals T2
  • Terminal 4: P4 car park. Module D, Floor 4

Uber

  • Terminal 1: P1 car park
  • Terminal 2: Arrivals express car park T2
  • Terminal 4: P4 car park. Module D, Floor 4


Metro

The Metro Madrid Begoña Station is an 8-minute walk from the UAM Faculty of Medicine campus. Attendees can take line 10 to the Begoña Station. View on Google Maps here and read more information about the Madrid Metro Network here.

Bus

The Arzobispo Morcillo-Facultad Medicina bus stop is right in front of the UAM Faculty of Medicine. Bus routes 67 & 132 both serve this stop. Click here for EMT Madrid bus ticket rates.

Parking

The parking lot adjacent to the UAM Aula Magna is restricted to UAM faculty and students only and will not be accessible to Cancer Imaging workshop attendees.

However, Attendees can park nearby at the Sols-Morreale Biomedical Research Institute (IIBM) building. It is located just behind UAM – Faculty of Medicine. Parking is also available behind the UAM Laboratory building.

Click here for more information about how to get to the UAM Medical Campus.


Accommodations

Hotel accommodations are NOT included with registration fees of the Cancer Imaging workshop; attendees are responsible for booking their own accommodations.

Accommodations Nearby

Eurostars Madrid Tower

1.1 km away

P.º de la Castellana, 259, B, Fuencarral-El Pardo

28046 Madrid, Spain

+34 913 342 700

Home42 MADRID

1.3 km away

C. de San Modesto, 42, Fuencarral-El Pardo

28034 Madrid, Spain

+34 910 440 841

Barceló Imagine

1.8 km away

C. de Agustín de Foxá, 32, Chamartín

28036 Madrid, Spain

+34 917 327 019

Hotel Villamadrid

1.9 km away

Calle Xaudaró, 2, Fuencarral-El Pardo

28034 Madrid, Spain

+34 912 535 000

Hotel Madrid Chamartín Affiliated by Meliá

2.4 km away

C. de Mauricio Ravel, 10, Chamartín

28046 Madrid, Spain

+34 917 333 400

Holiday Inn Madrid - Las Tablas by IHG

6.8 km away

Calle de María Tubau, 16, Fuencarral-El Pardo

28050 Madrid, Spain

+34 913 586 400